Perform Another (Advanced) Search

1.  Newly Approved Drug Therapies (367) Ketoprofen, Schein Pharmaceutical,
...Newly Approved Drug Therapies (367) Ketoprofen, Schein Pharmaceutical, Drug Information The following information is obtained from various newswires, published medical journal articles, and medical conference presentations. Drug Name: Ketoprofen Company: Schein Pharmaceutical Approval Status: Approved December 1997 Treatment Area: anti-inflammatory General Information Ketoprofen ...
View Page

2.  CenterWatch: Rheumatology Approved Drug Therapies
...of Lodine, Approved December 1997 Etodolac ; Royce Laboratories; Generic equivalent of Lodine, Approved April 1997 Ketoprofen ; Schein Pharmaceutical; Generic equivalent or Oruvail, Approved December 1997 Synvisc, Synvisc-One (Hylan GF 20 ...
View Page

3.  CenterWatch: Musculoskeletal Approved Drug Therapies
...1997 Evista (raloxifene hydrochloride) ; Eli Lilly; Treatment for the prevention of osteoporosis, Approved December 1997 Ketoprofen ; Schein Pharmaceutical; Generic equivalent or Oruvail, Approved December 1997 Skelid (tiludronate disodium) ; Sanofi-aventis; Treatment ...
View Page

4.  CenterWatch: List of Newly Approved Drug Thearapies
...1997 Evista (raloxifene hydrochloride) ; Eli Lilly; Treatment for the prevention of osteoporosis, Approved December 1997 Ketoprofen ; Schein Pharmaceutical; Generic equivalent or Oruvail, Approved December 1997 Skelid (tiludronate disodium) ; Sanofi-aventis; Treatment ...
...of Lodine, Approved December 1997 Etodolac ; Royce Laboratories; Generic equivalent of Lodine, Approved April 1997 Ketoprofen ; Schein Pharmaceutical; Generic equivalent or Oruvail, Approved December 1997 Synvisc, Synvisc-One (Hylan GF 20 ...
View Page